On December 3, 2013, The Lancet published Global Health 2035: A World Converging within a Generation. This major new report was prepared by The Lancet Commission on Investing in Health (CIH), co-chaired by DCP3 series editor, and University of Washington Professor Dean Jamison, PhD, and chaired by Lawrence H. Summers, PhD, President Emeritus and Charles W. Eliot University Professor of Harvard University, and former U.S. Treasury Secretary.

The Global Health 2035 report is being released on the 20th anniversary of the 1993 World Development Report, published by the World Bank, which became a landmark in establishing the economic development case for global health expenditure. Global Health 2035: A World Converging within a Generation revisits the case for investing in health and puts forth a bold new investment framework to achieve dramatic health gains by 2035.  

The Commission found that:

  • The returns on investing in health are even greater than previously estimated.
  • Within a generation—by 2035—the world could achieve a "grand convergence," bringing preventable infectious, maternal and child deaths down to universally low levels.
  • Taxes and subsidies are a powerful and underused lever for curbing non-communicable diseases and injuries.
  • Progressive universalism, a pathway to universal health coverage (UHC) that targets the poor from the outset, is an efficient way to achieve health and financial protection.

About the Commission  

The World Bank's 1993 World Development Report (WDR 1993), Investing in Health, is credited for having helped to place health firmly on the global development agenda. The report's central argument was that well-chosen health expenditures are an investment in economic prosperity, and individual wellbeing, rather than a drain on the economy. Healthier populations have better education outcomes, and are more economically productive.

Prompted by the report's 20th anniversary, an international multi-disciplinary group of 25 Commissioners has been meeting since December 2012 to revisit the case for investing in health, and examine it in light of current and future needs and opportunities.